Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Pigmented purpura dermatosis and viral hepatitis: a case-control study.

Ehsani AH, Ghodsi SZ, Nourmohammad-Pour P, Aghazadeh N, Damavandi MR.

Australas J Dermatol. 2013 Aug;54(3):225-7. doi: 10.1111/ajd.12003. Epub 2012 Nov 29.

PMID:
23190427
2.
3.

HBV and HCV infection in Japanese dental care workers.

Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.

Int J Mol Med. 2008 Jun;21(6):791-9.

PMID:
18506374
4.

Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).

Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, Nassiri R.

Med Sci Monit. 2002 Dec;8(12):CR797-800.

PMID:
12503038
5.

Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.

Gohar SA, Khalil RY, Elaish NM, Khedr EM, Ahmed MS.

J Egypt Public Health Assoc. 1995;70(5-6):465-84.

PMID:
17214170
6.

Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand.

Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D.

J Clin Virol. 2002 Feb;24(1-2):31-5.

PMID:
11744426
7.

Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.

Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95.

PMID:
22864260
8.

Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.

Ghavanini AA, Sabri MR.

East Mediterr Health J. 2000 Sep-Nov;6(5-6):1114-6.

PMID:
12197336
9.

Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.

Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ.

Afr Health Sci. 2012 Sep;12(3):312-7.

10.

Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.

Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM.

Mem Inst Oswaldo Cruz. 2003 Jul;98(5):599-603.

PMID:
13677340
11.

Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.

Resnick RH, Koff R.

Arch Intern Med. 1993 Jul 26;153(14):1672-7.

PMID:
7687423
12.

Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.

Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.

Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z. Epub 2013 Apr 4.

PMID:
23553454
13.

[Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].

Dray X, Dray-Spira R, Bronstein JA, Mattera D.

Med Trop (Mars). 2005;65(1):39-42. French.

PMID:
15903075
14.

High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.

Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.

Liver Int. 2009 Apr;29(4):518-24. doi: 10.1111/j.1478-3231.2009.01975.x. Epub 2009 Jan 22.

PMID:
19192168
15.

Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?

Ibrahim HA, Baddour MM, Morsi MG, Abdelkader AA.

East Mediterr Health J. 1999 Jan;5(1):71-8.

PMID:
10793783
16.

Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.

Atanasova MV, Haydouchka IA, Zlatev SP, Stoilova YD, Iliev YT, Mateva NG.

Minerva Gastroenterol Dietol. 2004 Mar;50(1):89-96.

PMID:
15719010
17.

HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.

Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.

Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.

18.

Serum hepatitis C virus and hepatitis B surface antigenaemia in Nigerian patients with acute icteric hepatitis.

Ola SO, Otegbayo JA, Odaibo GN, Olaleye OD, Olubuyide OL.

West Afr J Med. 2002 Jul-Sep;21(3):215-7.

PMID:
12744571
19.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
20.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109

Supplemental Content

Support Center